Page last updated: 2024-09-04

10-propargyl-10-deazaaminopterin and Hodgkin Disease

10-propargyl-10-deazaaminopterin has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duffull, SB; Fleisher, M; Hamlin, P; Horwitz, S; Mould, DR; Neylon, E; O'Connor, OA; Saunders, ME; Sirotnak, F; Sweeney, K1

Other Studies

1 other study(ies) available for 10-propargyl-10-deazaaminopterin and Hodgkin Disease

ArticleYear
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
    Clinical pharmacology and therapeutics, 2009, Volume: 86, Issue:2

    Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Area Under Curve; Biomarkers; Body Size; Drug Administration Schedule; Female; Folic Acid Antagonists; Hodgkin Disease; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Methylmalonic Acid; Middle Aged; Models, Statistical; Mucositis; Predictive Value of Tests; Recurrence; Severity of Illness Index; Vitamin B 12

2009